Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Colpaert

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
Atherosclerosis|February 27, 2001
F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched dietD Junquero, F Bruniquel, X N'Guyen, et al.
Biochemical Pharmacology|January 4, 2001
Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitorD Junquero, P Oms, E Carilla-Durand, et al.
British Journal of Pharmacology|May 1, 1995
Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivoF Bertolino, J P Valentin, M Maffre, et al.
Biochemical Pharmacology|February 28, 2001
Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in cultureD Junquero, A Pilon, E Carilla-Durand, et al.
British Journal of Pharmacology|January 22, 2009
Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonistA Newman-Tancredi, J-C Martel, M-B Assié, et al.
Neuropharmacology|November 9, 2002
Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesiaF C Colpaert, J P Tarayre, W Koek, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998
F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potentialW Koek, J F Patoiseau, M B Assié, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraineG W John, P J Pauwels, M Perez, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
Atherosclerosis|February 27, 2001
F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched dietD Junquero, F Bruniquel, X N'Guyen, et al.
Biochemical Pharmacology|January 4, 2001
Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitorD Junquero, P Oms, E Carilla-Durand, et al.
British Journal of Pharmacology|May 1, 1995
Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivoF Bertolino, J P Valentin, M Maffre, et al.
Biochemical Pharmacology|February 28, 2001
Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in cultureD Junquero, A Pilon, E Carilla-Durand, et al.
British Journal of Pharmacology|January 22, 2009
Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonistA Newman-Tancredi, J-C Martel, M-B Assié, et al.
Neuropharmacology|November 9, 2002
Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesiaF C Colpaert, J P Tarayre, W Koek, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998
F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potentialW Koek, J F Patoiseau, M B Assié, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraineG W John, P J Pauwels, M Perez, et al.
Pageof 16